Search
for
Sort by
Research 451–480 of 1000+
- 8483 Changes in kidney hemodynamics during gender-affirming hormone therapy in transgender individuals - findings from the KNIGHT pilot study
- MON-317 Prognostic Factors and Mortality According to the Structural and Functional Classification of Acromegaly
- MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Mood disorders and quality of life in polycystic ovary syndrome
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism
- Effect of finasteride in idiopathic hirsutism
- Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation
- Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients.
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Spironolactone is an Effective and Well Tolerated Systemic Antiandrogen Therapy for Hirsute Women*
- Caring for women with polycystic ovary syndrome
- Testosterone therapy for transgender men
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- A Clinical Approach to Severe Insulin Resistance
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- Assessment of chemokines MIP-1α and MIP-1 βin Iraqi women with polycystic ovarian syndrome
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Frequency of androgenic alopecia in patients presenting with polycystic ovarian syndrome at tertiary care hospital Karachi.